To access the full report, click on the PDF (only visible when logged-in).
Amgen, Inc. – AMGN: Confirmed, Undisclosed SEC Investigation. We tracked undisclosed SEC investigative activity off-and-on at Amgen dating back to Sep-2013. The first Freedom of Information Act (FOIA) response indicating a new SEC investigation was dated 18-Apr-2019, and later confirmed in an appeal response dated 23-May-2019.
Clients are invited to contact us anytime, in total confidence, to discuss how to better assess the risks we identify here.
To learn more on our process and what our findings mean, click here.
Note: New SEC investigative activity could theoretically begin or end after the date covered by this latest information which would not be reflected here.
This article is premium content. To continue reading, please Sign In or Join at the top of this page.
